Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Medicina clínica 149 (10), 441-448, 2017 | 303 | 2017 |
Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, ... Health Policy 116 (2-3), 188-195, 2014 | 42 | 2014 |
Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool D Vivas-Consuelo, R Usó-Talamantes, N Guadalajara-Olmeda, ... BMC health services research 14, 1-11, 2014 | 27 | 2014 |
Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain R Cantón, R Huarte, L Morata, JL Trillo-Mata, R Muñoz, J González, ... Enfermedades Infecciosas y Microbiología Clínica 39 (4), 179-183, 2021 | 18 | 2021 |
Epidemiología y caracterización sociodemográfica de la fibromialgia en la Comunidad Valenciana A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Revista española de salud pública 93, e201912099, 2020 | 17 | 2020 |
Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study J Sanfélix-Genovés, S Peiró, G Sanfélix-Gimeno, I Hurtado, ... BMC Health Services Research 10, 1-7, 2010 | 12 | 2010 |
Sistema de Prescripción y dispensación electrónica en la Agencia Valenciana de Salud E De la Poza, I Barrachina Martínez, JL Trillo Mata, R Usó Talamantes El profesional de la información 20 (3), 332-339, 2011 | 11 | 2011 |
Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis MT Álvarez-Román, I Cuervo-Arango, R Pérez-Santamarina, JL Poveda, ... Global & Regional Health Technology Assessment 2019, 2284240319880534, 2019 | 9 | 2019 |
Desarrollo del indicador Población Estandarizada Equivalente para el control del gasto farmacéutico ambulatorio M Caballer Tarazona, L Buigues Pastor, I Saurí Ferrer, R Usó Talamantes, ... Revista Española de Salud Pública 86 (4), 371-380, 2012 | 6 | 2012 |
Cost of Type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in Spain R Usó-Talamantes, S González-de-Julián, J Díaz-Carnicero, ... International Journal of Environmental Research and Public Health 18 (18), 9853, 2021 | 5 | 2021 |
Methods to control the pharmaceutical cost impact of chronic conditions in the elderly D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, P Mendez-Valera Expert Review of Pharmacoeconomics & Outcomes Research 15 (3), 425-437, 2015 | 5 | 2015 |
Influencia de las características del médico de AP y del cupo en el precio medio de la recetay el porcentaje de genéricos prescritos en un área de salud de la Comunidad Valenciana V Pedrera Carbonell, H Schwarz Chavarri, M Pascual de la Torre, ... Cuad. gest. prof. aten. prim.(Ed. impr.), 157-165, 2003 | 4 | 2003 |
Analysis of potentially inappropriate prescriptions according to the START criteria in nursing homes D Planelles, S Ferrer, JL Trillo-Mata, J Navarro-Pérez Revista Espanola de Geriatria y Gerontologia 56 (4), 195-202, 2021 | 3 | 2021 |
Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos AC Meseguer, G Cerdá-Olmedo, JLT Mata Medicina clínica 149 (10), 441-448, 2017 | 3 | 2017 |
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis A Gil-Nagel, M Falip, R Sánchez-Carpintero, MR Abad-Sazatornil, ... Epilepsy & Behavior 132, 108711, 2022 | 2 | 2022 |
Epidemiology and sociodemographic characterization of the fibromyalgia in Comunidad Valenciana A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Revista Espanola de Salud Publica 93, e201912099-e201912099, 2019 | 2 | 2019 |
Gestor informatizado de prestación farmacéutica: evaluación de la satisfacción social y modelización del gasto farmacéutico ajustado por las condiciones crónicas de los pacientes JL Trillo Mata Universitat Politècnica de València, 2013 | 2 | 2013 |
Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions R Usó Talamantes, JL Trillo Mata, MN Guadalajara Olmeda, ... Value in Health 15 (7), A297-A297, 2012 | 2 | 2012 |
PIN109 DETERMINING THE BURDEN OF CARBAPENEM-RESISTANT GRAM-NEGATIVE INFECTIONS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA) JL Alfonso, R Cantón, R Ferrer, J González, V Hernández, R Huarte, ... Value in Health 22, S656-S657, 2019 | 1 | 2019 |
Electronic prescription and dispensation pharmaceutical system at the Health Valencian Agency, Spain E De-la-Poza-Plaza, I Barrachina-Martinez, JL Trillo-Mata, ... PROFESIONAL DE LA INFORMACION 20 (3), 332-339, 2011 | 1 | 2011 |